These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6134562)

  • 1. Low CSF concentrations of cyclic GMP in schizophrenia.
    Gattaz WF; Cramer H; Beckmann H
    Br J Psychiatry; 1983 Mar; 142():288-91. PubMed ID: 6134562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haloperidol increases the cerebrospinal fluid concentrations of cyclic GMP in schizophrenic patients.
    Gattaz WF; Cramer H; Beckmann H
    Biol Psychiatry; 1984 Aug; 19(8):1229-35. PubMed ID: 6149769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic GMP in the CSF of patients with schizophrenia before and after neuroleptic treatment.
    Ebstein RP; Biederman J; Rimon R; Zohar J; Belmaker RH
    Psychopharmacology (Berl); 1976 Dec; 51(1):71-4. PubMed ID: 13448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnesium and calcium in the CSF of schizophrenic patients and healthy controls: correlations with cyclic GMP.
    Gattaz WF; Kattermann R; Gattaz D; Beckmann H
    Biol Psychiatry; 1983 Aug; 18(8):935-9. PubMed ID: 6137251
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased CSF cortisol levels after neuroleptic treatment in schizophrenia.
    Gattaz WF; Hannak D; Beckmann H
    Psychoneuroendocrinology; 1985; 10(3):351-4. PubMed ID: 2865767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidimensional analysis of the concentrations of 17 substances in the CSF of schizophrenics and controls.
    Gattaz WF; Gasser T; Beckmann H
    Biol Psychiatry; 1985 Apr; 20(4):360-6. PubMed ID: 2858227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidimensional analysis of the concentrations of 17 substances in the CSF of schizophrenics and controls.
    Beckmann H; Gattaz WF
    J Neural Transm (Vienna); 2002 May; 109(5-6):931-8. PubMed ID: 12111479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutamate in schizophrenics and healthy controls.
    Gattaz WF; Gattaz D; Beckmann H
    Arch Psychiatr Nervenkr (1970); 1982; 231(3):221-5. PubMed ID: 6123303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin immunoreactivity in cerebrospinal fluid of schizophrenic patients and healthy controls.
    Beckmann H; Wetterberg L; Gattaz WF
    Psychiatry Res; 1984 Feb; 11(2):107-10. PubMed ID: 6143334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenylethylamine and phenylacetic acid in CSF of schizophrenics and healthy controls.
    Beckmann H; Reynolds GP; Sandler M; Waldmeier P; Lauber J; Riederer P; Gattaz WF
    Arch Psychiatr Nervenkr (1970); 1983; 232(6):463-71. PubMed ID: 6134517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine and noradrenalin in the cerebrospinal fluid of schizophrenic patients.
    Gattaz WF; Riederer P; Reynolds GP; Gattaz D; Beckmann H
    Psychiatry Res; 1983 Apr; 8(4):243-50. PubMed ID: 6576391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low angiotensin-converting enzyme activity (kininase II) in cerebrospinal fluid of schizophrenics.
    Beckmann H; Saavedra JM; Gattaz WF
    Biol Psychiatry; 1984 May; 19(5):679-84. PubMed ID: 6145452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in chronic schizophrenic patients with tardive dyskinesia or drug-induced tremor.
    Nagao T; Ohshimo T; Mitsunobu K; Sato M; Otsuki S
    Biol Psychiatry; 1979 Jun; 14(3):509-23. PubMed ID: 38867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subnormal CSF levels of neurotensin in a subgroup of schizophrenic patients: normalization after neuroleptic treatment.
    Widerlöv E; Lindström LH; Besev G; Manberg PJ; Nemeroff CB; Breese GR; Kizer JS; Prange AJ
    Am J Psychiatry; 1982 Sep; 139(9):1122-6. PubMed ID: 6126127
    [No Abstract]   [Full Text] [Related]  

  • 15. Vasopressin--oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls.
    Beckmann H; Lang RE; Gattaz WF
    Psychoneuroendocrinology; 1985; 10(2):187-91. PubMed ID: 4034849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid cyclic guanosine 3'5' monophosphate levels in Parkinson's disease.
    Navarro JA; Jiménez-Jiménez FJ; Molina JA; Benito-León J; Cisneros E; Gasalla T; Ortí-Pareja M; Tallón-Barranco A; de Bustos F; Arenas J
    J Neurol Sci; 1998 Feb; 155(1):92-4. PubMed ID: 9562329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Paranoid schizophrenia: free amino acids in the cerebrospinal fluid].
    Prieto-Rincón D; Piñerúa-Shuhaibar L; Bonilla E; Prasad A; Arrieta A
    Invest Clin; 1991; 32(4):149-55. PubMed ID: 1688037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the phosphodiesterase 2 inhibitor BI 474121 on central nervous system cyclic guanosine monophosphate concentrations: Translational studies.
    van Kraaij S; Goeldner RG; Rosenbrock H; Groeneveld GJ; Kremer P; Schaible J; Zambori J; Schultheis C
    Br J Clin Pharmacol; 2024 Oct; 90(10):2517-2528. PubMed ID: 38880932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observations on the cyclic nucleotide concentrations in human cerebrospinal fluid.
    Rudman D; O'Brien MS; McKinney AS; Hoffman JC; Patterson JH
    J Clin Endocrinol Metab; 1976 Jun; 42(6):1088-97. PubMed ID: 180045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Beta-endorphin concentration in the cerebrospinal fluid of schizophrenics].
    Ignatov SA; Burbaeva GSh; Tsutsul'kovskaia MIa; Abramova LI; Trubnikov VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(9):1331-7. PubMed ID: 6108032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.